Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2018-06-25 GARDNER JASON See Remarks Conversion +21,677 359,092
2018-06-25 GARDNER JASON See Remarks Purchase +400 $15.00 $6K 363,212
2018-06-25 GARDNER JASON See Remarks Conversion · Series A Preferred Stock −30,000 0
2018-06-25 GARDNER JASON See Remarks Conversion · Series A Preferred Stock −36,700 0
2018-06-25 GARDNER JASON See Remarks Conversion · Series B Preferred Stock −15,000 0
2018-06-25 GARDNER JASON See Remarks Conversion · Series B Preferred Stock −19,314 0
2018-06-25 GARDNER JASON See Remarks Conversion · Series C Preferred Stock −21,459 0
2018-06-25 Borisy Alexis Director Conversion +0 0
2018-06-25 Borisy Alexis Director Conversion · Series A Preferred Stock −0 0
2018-06-25 Borisy Alexis Director Conversion · Series B Preferred Stock −0 0

Page 24 of 24 · 470 trades